Report Detail

Medical Devices & Consumables Global Papillary Thyroid Carcinoma Treatment Market Growth (Status and Outlook) 2022-2028

  • RnM4495470
  • |
  • 23 November, 2022
  • |
  • Global
  • |
  • 104 Pages
  • |
  • LPI(LP Information)
  • |
  • Medical Devices & Consumables

Papillary cancer and its variants. Most cancers are treated with removal of the thyroid gland (thyroidectomy), although small tumors that have not spread outside the thyroid gland may be treated by just removing the side of the thyroid containing the tumor (lobectomy).

The global market for Papillary Thyroid Carcinoma Treatment is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Papillary Thyroid Carcinoma Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Papillary Thyroid Carcinoma Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Papillary Thyroid Carcinoma Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Papillary Thyroid Carcinoma Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Papillary Thyroid Carcinoma Treatment players cover Abbott Laboratories, Roche Holding AG, Thermo Fisher Scientific Inc, Siemens Healthineers and Bio-Rad Laboratories, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Papillary Thyroid Carcinoma Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Papillary Thyroid Carcinoma Treatment market, with both quantitative and qualitative data, to help readers understand how the Papillary Thyroid Carcinoma Treatment market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Papillary Thyroid Carcinoma Treatment market and forecasts the market size by Type (Surgery, Iodine Therapy and Thyroxin Treatment), by Application (Hospital, Clinics and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Surgery
Iodine Therapy
Thyroxin Treatment
External Radiotherapy
Chemotherapy
Other

Segmentation by application
Hospital
Clinics
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Abbott Laboratories
Roche Holding AG
Thermo Fisher Scientific Inc
Siemens Healthineers
Bio-Rad Laboratories
Agilent Technologies
Illumina
Hologic
Leica Biosystems Nussloch GmbH
FUJIFILM Holdings Corporation
Merck KGaA
Beckman Coulter
Randox Laboratories

Chapter Introduction
Chapter 1: Scope of Papillary Thyroid Carcinoma Treatment, Research Methodology, etc.
Chapter 2: Executive Summary, global Papillary Thyroid Carcinoma Treatment market size and CAGR, Papillary Thyroid Carcinoma Treatment market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Papillary Thyroid Carcinoma Treatment revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Papillary Thyroid Carcinoma Treatment revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Papillary Thyroid Carcinoma Treatment market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Abbott Laboratories, Roche Holding AG, Thermo Fisher Scientific Inc, Siemens Healthineers, Bio-Rad Laboratories, Agilent Technologies, Illumina, Hologic and Leica Biosystems Nussloch GmbH, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Papillary Thyroid Carcinoma Treatment Market Size 2017-2028
    • 2.1.2 Papillary Thyroid Carcinoma Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Papillary Thyroid Carcinoma Treatment Segment by Type
    • 2.2.1 Surgery
    • 2.2.2 Iodine Therapy
    • 2.2.3 Thyroxin Treatment
    • 2.2.4 External Radiotherapy
    • 2.2.5 Chemotherapy
    • 2.2.6 Other
  • 2.3 Papillary Thyroid Carcinoma Treatment Market Size by Type
    • 2.3.1 Papillary Thyroid Carcinoma Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Papillary Thyroid Carcinoma Treatment Market Size Market Share by Type (2017-2022)
  • 2.4 Papillary Thyroid Carcinoma Treatment Segment by Application
    • 2.4.1 Hospital
    • 2.4.2 Clinics
    • 2.4.3 Others
  • 2.5 Papillary Thyroid Carcinoma Treatment Market Size by Application
    • 2.5.1 Papillary Thyroid Carcinoma Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Papillary Thyroid Carcinoma Treatment Market Size Market Share by Application (2017-2022)

3 Papillary Thyroid Carcinoma Treatment Market Size by Player

  • 3.1 Papillary Thyroid Carcinoma Treatment Market Size Market Share by Players
    • 3.1.1 Global Papillary Thyroid Carcinoma Treatment Revenue by Players (2020-2022)
    • 3.1.2 Global Papillary Thyroid Carcinoma Treatment Revenue Market Share by Players (2020-2022)
  • 3.2 Global Papillary Thyroid Carcinoma Treatment Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Papillary Thyroid Carcinoma Treatment by Regions

  • 4.1 Papillary Thyroid Carcinoma Treatment Market Size by Regions (2017-2022)
  • 4.2 Americas Papillary Thyroid Carcinoma Treatment Market Size Growth (2017-2022)
  • 4.3 APAC Papillary Thyroid Carcinoma Treatment Market Size Growth (2017-2022)
  • 4.4 Europe Papillary Thyroid Carcinoma Treatment Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Papillary Thyroid Carcinoma Treatment Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Papillary Thyroid Carcinoma Treatment Market Size by Country (2017-2022)
  • 5.2 Americas Papillary Thyroid Carcinoma Treatment Market Size by Type (2017-2022)
  • 5.3 Americas Papillary Thyroid Carcinoma Treatment Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Papillary Thyroid Carcinoma Treatment Market Size by Region (2017-2022)
  • 6.2 APAC Papillary Thyroid Carcinoma Treatment Market Size by Type (2017-2022)
  • 6.3 APAC Papillary Thyroid Carcinoma Treatment Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Papillary Thyroid Carcinoma Treatment by Country (2017-2022)
  • 7.2 Europe Papillary Thyroid Carcinoma Treatment Market Size by Type (2017-2022)
  • 7.3 Europe Papillary Thyroid Carcinoma Treatment Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Papillary Thyroid Carcinoma Treatment by Region (2017-2022)
  • 8.2 Middle East & Africa Papillary Thyroid Carcinoma Treatment Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Papillary Thyroid Carcinoma Treatment Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Papillary Thyroid Carcinoma Treatment Market Forecast

  • 10.1 Global Papillary Thyroid Carcinoma Treatment Forecast by Regions (2023-2028)
    • 10.1.1 Global Papillary Thyroid Carcinoma Treatment Forecast by Regions (2023-2028)
    • 10.1.2 Americas Papillary Thyroid Carcinoma Treatment Forecast
    • 10.1.3 APAC Papillary Thyroid Carcinoma Treatment Forecast
    • 10.1.4 Europe Papillary Thyroid Carcinoma Treatment Forecast
    • 10.1.5 Middle East & Africa Papillary Thyroid Carcinoma Treatment Forecast
  • 10.2 Americas Papillary Thyroid Carcinoma Treatment Forecast by Country (2023-2028)
    • 10.2.1 United States Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.2.2 Canada Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.2.3 Mexico Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.2.4 Brazil Papillary Thyroid Carcinoma Treatment Market Forecast
  • 10.3 APAC Papillary Thyroid Carcinoma Treatment Forecast by Region (2023-2028)
    • 10.3.1 China Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.3.2 Japan Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.3.3 Korea Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.3.4 Southeast Asia Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.3.5 India Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.3.6 Australia Papillary Thyroid Carcinoma Treatment Market Forecast
  • 10.4 Europe Papillary Thyroid Carcinoma Treatment Forecast by Country (2023-2028)
    • 10.4.1 Germany Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.4.2 France Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.4.3 UK Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.4.4 Italy Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.4.5 Russia Papillary Thyroid Carcinoma Treatment Market Forecast
  • 10.5 Middle East & Africa Papillary Thyroid Carcinoma Treatment Forecast by Region (2023-2028)
    • 10.5.1 Egypt Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.5.2 South Africa Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.5.3 Israel Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.5.4 Turkey Papillary Thyroid Carcinoma Treatment Market Forecast
    • 10.5.5 GCC Countries Papillary Thyroid Carcinoma Treatment Market Forecast
  • 10.6 Global Papillary Thyroid Carcinoma Treatment Forecast by Type (2023-2028)
  • 10.7 Global Papillary Thyroid Carcinoma Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Information
    • 11.1.2 Abbott Laboratories Papillary Thyroid Carcinoma Treatment Product Offered
    • 11.1.3 Abbott Laboratories Papillary Thyroid Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Abbott Laboratories Main Business Overview
    • 11.1.5 Abbott Laboratories Latest Developments
  • 11.2 Roche Holding AG
    • 11.2.1 Roche Holding AG Company Information
    • 11.2.2 Roche Holding AG Papillary Thyroid Carcinoma Treatment Product Offered
    • 11.2.3 Roche Holding AG Papillary Thyroid Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Roche Holding AG Main Business Overview
    • 11.2.5 Roche Holding AG Latest Developments
  • 11.3 Thermo Fisher Scientific Inc
    • 11.3.1 Thermo Fisher Scientific Inc Company Information
    • 11.3.2 Thermo Fisher Scientific Inc Papillary Thyroid Carcinoma Treatment Product Offered
    • 11.3.3 Thermo Fisher Scientific Inc Papillary Thyroid Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Thermo Fisher Scientific Inc Main Business Overview
    • 11.3.5 Thermo Fisher Scientific Inc Latest Developments
  • 11.4 Siemens Healthineers
    • 11.4.1 Siemens Healthineers Company Information
    • 11.4.2 Siemens Healthineers Papillary Thyroid Carcinoma Treatment Product Offered
    • 11.4.3 Siemens Healthineers Papillary Thyroid Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Siemens Healthineers Main Business Overview
    • 11.4.5 Siemens Healthineers Latest Developments
  • 11.5 Bio-Rad Laboratories
    • 11.5.1 Bio-Rad Laboratories Company Information
    • 11.5.2 Bio-Rad Laboratories Papillary Thyroid Carcinoma Treatment Product Offered
    • 11.5.3 Bio-Rad Laboratories Papillary Thyroid Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Bio-Rad Laboratories Main Business Overview
    • 11.5.5 Bio-Rad Laboratories Latest Developments
  • 11.6 Agilent Technologies
    • 11.6.1 Agilent Technologies Company Information
    • 11.6.2 Agilent Technologies Papillary Thyroid Carcinoma Treatment Product Offered
    • 11.6.3 Agilent Technologies Papillary Thyroid Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Agilent Technologies Main Business Overview
    • 11.6.5 Agilent Technologies Latest Developments
  • 11.7 Illumina
    • 11.7.1 Illumina Company Information
    • 11.7.2 Illumina Papillary Thyroid Carcinoma Treatment Product Offered
    • 11.7.3 Illumina Papillary Thyroid Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Illumina Main Business Overview
    • 11.7.5 Illumina Latest Developments
  • 11.8 Hologic
    • 11.8.1 Hologic Company Information
    • 11.8.2 Hologic Papillary Thyroid Carcinoma Treatment Product Offered
    • 11.8.3 Hologic Papillary Thyroid Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Hologic Main Business Overview
    • 11.8.5 Hologic Latest Developments
  • 11.9 Leica Biosystems Nussloch GmbH
    • 11.9.1 Leica Biosystems Nussloch GmbH Company Information
    • 11.9.2 Leica Biosystems Nussloch GmbH Papillary Thyroid Carcinoma Treatment Product Offered
    • 11.9.3 Leica Biosystems Nussloch GmbH Papillary Thyroid Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Leica Biosystems Nussloch GmbH Main Business Overview
    • 11.9.5 Leica Biosystems Nussloch GmbH Latest Developments
  • 11.10 FUJIFILM Holdings Corporation
    • 11.10.1 FUJIFILM Holdings Corporation Company Information
    • 11.10.2 FUJIFILM Holdings Corporation Papillary Thyroid Carcinoma Treatment Product Offered
    • 11.10.3 FUJIFILM Holdings Corporation Papillary Thyroid Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 FUJIFILM Holdings Corporation Main Business Overview
    • 11.10.5 FUJIFILM Holdings Corporation Latest Developments
  • 11.11 Merck KGaA
    • 11.11.1 Merck KGaA Company Information
    • 11.11.2 Merck KGaA Papillary Thyroid Carcinoma Treatment Product Offered
    • 11.11.3 Merck KGaA Papillary Thyroid Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Merck KGaA Main Business Overview
    • 11.11.5 Merck KGaA Latest Developments
  • 11.12 Beckman Coulter
    • 11.12.1 Beckman Coulter Company Information
    • 11.12.2 Beckman Coulter Papillary Thyroid Carcinoma Treatment Product Offered
    • 11.12.3 Beckman Coulter Papillary Thyroid Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Beckman Coulter Main Business Overview
    • 11.12.5 Beckman Coulter Latest Developments
  • 11.13 Randox Laboratories
    • 11.13.1 Randox Laboratories Company Information
    • 11.13.2 Randox Laboratories Papillary Thyroid Carcinoma Treatment Product Offered
    • 11.13.3 Randox Laboratories Papillary Thyroid Carcinoma Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 Randox Laboratories Main Business Overview
    • 11.13.5 Randox Laboratories Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Papillary Thyroid Carcinoma Treatment. Industry analysis & Market Report on Papillary Thyroid Carcinoma Treatment is a syndicated market report, published as Global Papillary Thyroid Carcinoma Treatment Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Papillary Thyroid Carcinoma Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,045.12
6,090.24
3,528.24
7,056.48
507,202.80
1,014,405.60
298,399.80
596,799.60
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report